NOVARTIS PHARMA GMBH
Roonstrasse 25 – Nurnberg – 90429
VAT: DE133500876
www.novartis.de
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, NOVARTIS PHARMA GMBH has received € 0.0 for its participation in a total of 1 project(s) with a total cost of € 3,583,870.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | 642295 | MEL-PLEX | drug discovery · melanoma · simulation software · mathematical model | 2018-11-30 | partner | € nan | € 3,583,870 | 2 | 20 | CORDIS ↪ |
NOVARTIS PHARMA GMBH did not participate in complicit projects under Horizon Europe (2021-2027).
NOVARTIS PHARMA GMBH did not participate in complicit projects under FP7 (2007-2013).